What the six lenses say about SANOFI — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How SANOFI’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | -0.7pp | +1.2pp | -3.4pp | -4.1pp | -14.7pp | -34.5pp |
Nifty 500 Broad-market baseline | -0.7pp | +1.2pp | -4.5pp | -5.7pp | -20.5pp | -39.8pp |
Sector Own-sector index | — | — | -7.3pp | -11.8pp | -33.6pp | -60.5pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
SANOFI daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
SANOFI ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | Sep '24 | Dec '24 |
|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 706 | 715 | 694 | 732 | 464 | 524 | 515 |
| ↳ change QoQ | — | +1.2% | -2.9% | +5.5% | -36.7% | +13.1% | -1.7% |
| EBITDA (₹cr) | 194 | 220 | 199 | 199 | 102 | 122 | 132 |
| EBITDA margin | 27.5% | 30.8% | 28.7% | 27.1% | 21.9% | 23.3% | 25.7% |
| PAT (₹cr) | 123 | 152 | 138 | 137 | 103 | 82 | 91 |
| ↳ change QoQ | — | +23.6% | -9.4% | -0.8% | -24.5% | -20.4% | +11.1% |
| Net margin | 17.4% | 21.3% | 19.8% | 18.6% | 22.3% | 15.7% | 17.7% |
| EPS (₹) | 53.37 | 65.95 | 59.79 | 59.31 | 44.81 | 35.69 | 39.64 |
| D/E | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding SANOFI (4)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| Nippon India Pharma Bns | 1.07% | 9,279 | |
| Nippon India Pharma Gr | 1.07% | 9,279 | |
| Abakkus Small Cap Reg Gr | 1.40% | 2,113 | |
| Bandhan Healthcare Reg Gr | 1.45% | 319 |
ETFs holding SANOFI (0)
No tracked ETF holds SANOFI ≥0.5%.